The complex (bipy)2Cu(5,9-eicd)
was prepared by the
reaction of Cu(OAc)2 with 5Z,9Z-eicosadienoic acid and 2,2′-bipyridine in methanol.
The new copper complex showed high antitumor activity in vitro toward
A2780cis, A2780, Hek293, K562, HL60, Jurkat, and U937 cell lines and
efficiently inhibited human topoisomerase I. Using flow cytofluorometry,
(bipy)2Cu(5,9-eicd) was studied for the effect on the cell
cycle and apoptosis-inducing activity in tumor cells.